We previously developed an algorithm that uses fasting levels of 10- and 12-Z,E-HODE/LA, insulin, and leptin/adiponectin to assess the utility of biomarkers for detecting early-stage diabetes,(7,8) and used it here to evaluate IGT and insulin resistance, including in borderline cases. This evidence concerns the gene ADIPOQ and Insulin resistance.